Q4 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Sangrix(SGRX) the EBIT is 2.689 M (+595.6%);the EPS is -6.87 (+53.33%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
0.00B595.60%
----
----
EPS
-6.865953.33%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf